Physician profile
Laura E Dewalt
NPI 1396275228
$2,453.67
in general payments reported to CMS, 2019-2025
15 companies · $645 in 2025
The $645 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.77 · 2023: $828 · 2024: $889 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,247 · Education: $64.99 · Long Term Medical Supply Or Device Loan: $49.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,246.96 |
| Education | $64.99 |
| Long Term Medical Supply Or Device Loan | $49.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $856.38 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $284.59 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Bayer Healthcare Pharmaceuticals INC. | $249.87 | 2023-2024 | |
| Pfizer INC. | $174.79 | 2023-2025 | |
| Medtronic, INC. | $165.46 | 2023-2025 | Minimed 780g, Minimed 770g |
| Merck Sharp & Dohme LLC | $141.20 | 2023-2025 | Gardasil 9, M-M-R II, Gardasil |
| Astrazeneca Pharmaceuticals LP | $127.07 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Astellas Pharma US INC | $119.88 | 2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.52 | 2023-2025 | Jardiance, Synjardy, Tradjenta |
| Welch Allyn | $91.77 | 2021 | |
| Abbott Laboratories | $49.95 | 2025 | Freestyle Insulinx |
| Amneal Pharmaceuticals LLC | $33.94 | 2023 | Lyvispah |
| Qiagen, LLC | $17.39 | 2023 | |
| Glaxosmithkline, LLC. | $17.13 | 2025 | Bexsero, Penmenvy |
| Dynavax Technologies Corporation | $15.73 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Dewalt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.